Average Co-Inventor Count = 7.92
ph-index = 6
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Amgen Inc. (13 from 1,979 patents)
2. Biogen Ma Inc. (8 from 252 patents)
21 patents:
1. 12391697 - Condensed bi-heterocycles as inhibiting agents for Bruton's tyrosine kinase
2. 12240839 - Cyclobutyl dihydroquinoline sulfonamide compounds
3. 12240838 - Inhibiting agents for Bruton's tyrosine kinase
4. 11858926 - Inhibiting agents for bruton's tyrosine kinase
5. 11807634 - Cyclopropyl dihydroquinoline sulfonamide compounds
6. 11427577 - Inhibiting agents for Bruton's tyrosine kinase
7. 10961237 - Inhibiting agents for Bruton's tyrosine kinase
8. 10899753 - Inhibiting agents for Bruton's tyrosine kinase
9. 10227341 - Inhibiting agents for bruton's tyrosine kinase
10. 10189829 - Inhibiting agents for Bruton's tyrosine kinase
11. 9776995 - Bicyclic sulfonamide compounds as sodium channel inhibitors
12. 9458152 - Bicyclic sulfonamide compounds as sodium channel inhibitors
13. 9346798 - Dihydrobenzoxazine and tetrahydroquinoxaline sodium channel inhibitors
14. 9212182 - Bicyclic sulfonamide compounds as sodium channel inhibitors
15. 9079902 - Heteroaryl sodium channel inhibitors